11/14/2024 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:22 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q/A | |
11/14/2024 4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q/A | |
11/14/2024 4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 5:01 AM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) St George Street Capital (Filed by)
| Form SC 13G/A | |
11/04/2024 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
11/04/2024 4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
|
11/03/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
11/01/2024 4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEFA14A | |
11/01/2024 3:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEF 14A | |
10/28/2024 4:16 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEFA14A | |
10/28/2024 4:17 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form ARS | |
10/24/2024 5:12 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/18/2024 3:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/16/2024 4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form PRE 14A | |
10/15/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2024 5:01 AM | ASTRAZENECA PLC (Filed by) ASTRAZENECA PLC (Filed by) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024 6:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/07/2024 6:38 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Dovet Ltd (Reporting) Nirland Ltd (Reporting) Rowland Master Trust (Reporting) Stockton Ltd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 4:02 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Dovet Ltd (Reporting) Nirland Ltd (Reporting) Rowland Master Trust (Reporting) Stockton Ltd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:59 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Corvus Capital Ltd. (Filed by)
| Form SC 13D/A | |
09/19/2024 4:01 PM | Algo Holdings, Inc. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Corvus Capital Ltd. (Reporting) Regan Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 3:41 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
09/16/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
09/06/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/04/2024 3:44 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
08/19/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
08/16/2024 3:59 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 4:53 PM | Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:56 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
05/14/2024 3:05 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Intelmed LLC (Reporting) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Tapolczay David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
04/01/2024 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form NT 10-K | |
02/12/2024 11:51 AM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G/A | |
02/08/2024 12:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
01/10/2024 3:43 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/18/2023 3:14 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
12/17/2023 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
12/14/2023 4:16 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Sragovicz Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Tapolczay David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) McNealey Jennifer Isacoff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:50 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1/A | |
12/01/2023 3:52 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |